Gene delivery systems: Bridging the gap between recombinant viruses and artificial vectors

被引：70

作者：

Lehn, P ^{[1
]}

Fabrega, S ^{[1
]}

Oudrhiri, N ^{[1
]}

Navarro, J ^{[1
]}

机构：

[1] Hop Robert Debre, INSERM, U458, F-75019 Paris, France

来源：

ADVANCED DRUG DELIVERY REVIEWS | 1998年 / 30卷 / 1-3期

关键词：

transfection; infection; gene therapy; gene transfer; macromolecular assemblies; self-assembly; intracellular trafficking; packaging cells; conformational changes; nucleic acid structures;

D O I：

10.1016/S0169-409X(97)00102-6

中图分类号：

R9 [药学];

学科分类号：

1007 ;

摘要：

Although most research in the field of somatic gene therapy has investigated the use of recombinant viruses for transferring genes into somatic target cells, various methods for nonviral gene delivery have also been proposed. Both types of gene delivery systems have advantages and drawbacks. Schematically, viral vectors are particularly efficient for gene delivery, whereas nonviral systems are free of the difficulties associated with the use of recombinant viruses bur need to be further optimized to reach their full potential. In order to bridge the gap between viral vectors and synthetic reagents, we discuss here some specific features of the viral vector systems of today that could advantageously be taken into account for the design of improved nonviral gene delivery systems. Indeed, although nonviral systems differ fundamentally from viral systems, one possible approach towards enhanced artificial reagents aims at developing 'artificial viruses' that mimic the highly efficient processes of viral infection. (C) 1998 Elsevier Science B.V.

引用

页码：5 / 11

页数：7

共 29 条

[11]

HAYWOOD AM, 1994, J VIROL, V68, P1

[12]

JOLLY D, 1994, CANCER GENE THER, V1, P51

[13]

KNIPE DM, 1996, FIELDS VIROLOGY, P273

[14] PROSPECTS FOR THE USE OF ADENOASSOCIATED VIRUS AS A VECTOR FOR HUMAN GENE-THERAPY [J].